This compound is a piperazine-based pharmaceutical intermediate bearing both tert-butoxycarbonyl (Boc) and 9-fluorenylmethoxycarbonyl (Fmoc) protecting groups. It is designed for use in the synthesis of complex organic molecules, where the orthogonal protecting groups allow selective deprotection steps.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1034574-30-5
4-Boc-1-Fmoc-2-piperazinecarboxylic acid
pharmaceutical intermediate
5-Fluoro-2H-pyrazolo[3,4-b]pyridin-3-amine
pharmaceutical intermediate
Fmoc-N-methyl-L-leucine
pharmaceutical intermediate
2-Amino-4-(4-methylpiperazin-1-yl) benzoic acid tertbutyl ester
pharmaceutical intermediate
4-(4-Methylpiperazin-1-yl)-2-(2,2,2-trifluoro-N-(tetrahydro-2H-pyran-4-yl)acetamido)benzoic acid 2,2,2-trifluoroacetate
pharmaceutical intermediate
(R)-1-N-tert-Butoxycarbonyl-4-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-piperazine carboxylic acid
research compound
1-Boc-4-Fmoc-2-piperazinecarboxylic acid
pharmaceutical intermediate
4-Boc-1-Fmoc-2-Piperazine acetic acid
pharmaceutical intermediate
(2S)-4-(9H-fluoren-9-ylmethoxycarbonyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylic acid
ZVHNNCSUTNWKFC-NRFANRHFSA-N
CC(C)(C)OC(=O)N1CCN(C[C@H]1C(=O)O)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
—